Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Coal India among 4 stocks that hit 52-week highs & rallied up to 15% in a month
Despite the BSE Sensex falling 829 points to close at 76,034, four BSE 200 stocks—Aurobindo Pharma, Coal India, ABB India and NTPC—scaled fresh 52-week highs, signalling strong momentum and resilience amid broader market weakness.
India gains favour with global investors on returns, ESG momentum
India is maturing as a market in which foreign investors who take into account environmental, social and governance (ESG) factors are confident in dedicating more of their portfolio to, according to fund managers at the Indian Venture and Alternate Capital Association conclave in Mumbai, who cite the economy's scale, improving return outlook and advancing ESG standards as key differentiators.

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.
Market Trading Guide: Apollo Pipes among 3 stock recommendations for Tuesday
Sensex and Nifty plunged nearly 2% as rising crude oil prices, weak global cues and escalating West Asia tensions triggered heavy selling. Foreign fund outflows and a weaker rupee added pressure. Analysts recommend Apollo Pipes, Aurobindo Pharma and Tata Steel for potential short-term gains.

Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — 9 March 2026
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy today — Aditya Birla Sun Life Amc, Aster DM Healthcare, CG Power and Industrial Solutions, Astral, and Krishna Institute Of Medical Sciencs.
Market Trading Guide: Buy Balrampur Chini and Abbott India on Thursday for gains up to 5%
The Nifty fell 1.6% amid broad-based selling triggered by the Iran-Israel conflict, with financials, auto and energy stocks leading losses. Analysts flag weak momentum and advise a sell-on-rise approach, while recommending Balrampur Chini Mills and Abbott India for short-term gains.
Sai Life hits record high in weak market; rebounds 5% from day's low
Supported by solid demand, disciplined execution, and capex programs progressing as planned, Sai Life management remains confident in sustaining positive growth momentum.

Sensex Today | Stock Market Highlights: Nifty ends below 25,200 after sharp sell-off in last 30 minutes led by banks
Sensex Today | Stock Market LIVE Updates: The markets are under immense pressure. The Nifty index is down over 150 points, falling below the 25,300 mark. The Nifty Bank is also down, falling 400 points. The index is now below the 61,000 mark. Maruti Suzuki, Airtel, M&M and Cipla are the biggest losers.
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.

Elara Securities bets on pharma revival; picks Zydus Life, Sun Pharma, Aurobindo Pharma
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.
Mankind Pharma among 4 stocks showing bullish RSI upswing
Four Nifty200 stocks, including Mankind Pharma and Aurobindo Pharma, signalled strengthening momentum on February 25 as their RSI crossed above the 50 mark. The RSI Trending Up scan highlights improving price strength, often interpreted by traders as a potential buying opportunity amid sustained upward movement.
Lloyds Metals & Energy among 6 stocks flash bullish signals, indicating possible uptrend
Six Nifty500 stocks, including Lloyds Metals & Energy, Mankind Pharma and National Aluminium Company, formed a bullish White Marubozu pattern on February 25, signalling strong buying interest. The candlestick formation indicates sustained upward momentum, with traders viewing it as a potential early indicator of further price strength in the near term.